Real-time data improves visibility and speeds up issue detection, reducing downtime and delays. Live metrics enable faster, more effective production decisions and help optimize performance on the ...

Website traffic from AI agents and bots has eclipsed its human-generated counterpart for the first time, according to Cloudflare, an earlier-than-expected milestone that speaks to AI’s rapid advance ...

The service could make it simpler and cheaper to develop grounded applications by reducing the need for custom web-search infrastructure, analysts say. For the past two years, enterprises have focused ...

The Federal Bureau of Investigation announced plans to buy nationwide access to a network of license plate readers, saying it will award contracts to one or more vendors that can offer “near real time ...

Companies like Lovable, Base44, Replit, and Netlify use AI to let anyone build a web app in seconds—and in thousands of cases, spill highly sensitive data onto the public internet. Security researcher ...

SQLite has an incredibly small footprint. The database itself, its DLLs and the complimentary diff and analyzer tools are less than 15 MB in size. It's perfect for small mobile devices, advanced ...

Abstract: This paper designs an Internet of Things system (called JustIoT) which is mainly divided into four parts; back-end Google Firebase real-time database, front-end SPA (Single Page Application) ...

WHITE OAK, MD – The US Food and Drug Administration (FDA) has announced plans for a future pilot program intended to facilitate the real-time review of clinical trials by regulators, as well as the ...

On a press call, FDA Commissioner Marty Makary, M.D., highlighted the potential for FDA staff to keep up with trials as they are happening and potentially make regulatory decisions without having to ...

Why does it take a new drug 10 years, on average, to come to market? Part of the reason lies in the dead time in the process. Historically, trials have required tedious tabulations and repeated ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.